Federal Food and Nutrition Grants

This grant provides funding to state agencies that manage the Supplemental Nutrition Assistance Program to implement measures that prevent and detect fraud, particularly related to the misuse of EBT cards.

This funding opportunity supports U.S.-based small businesses in health-related fields to develop innovative technologies, with a focus on projects that can successfully transition to commercialization.

The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury.Applicants will research and propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from over-the-counter (OTC) skin lightening products.

Not Available

This funding opportunity provides financial support to institutions with limited NIH funding to enhance their biomedical research capabilities and engage students in scientific inquiry.

This funding opportunity provides financial support for new researchers from diverse backgrounds to conduct small-scale health-related studies, helping them advance towards independent research careers.

This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P and F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

The purpose of this cooperative agreement is to contribute to the knowledge base of and development of food safety systems globally due to the increasingly diverse and complex food supply. This cooperative agreement will:1) enhance and broaden FDAs ability to address global food safety and public health issues associated with food,2) provide opportunities to leverage additional resources among WTO member countries, and3) support the FDAs Food Safety Modernization Act (FSMA) and its International Food Safety Capacity Building Plan, which emphasizes the concept of preventing food safety- related problems before they occur and the importance of establishing strong relationships and mutual support among all stakeholders, including multilateral organizations, to improve worldwide food safety. 4) Support global research and capacity building to improve best practices to build effective food safety systems in low- and middle-income countries

FY 2024 WIC General Infrastructure Grants will support WIC State agencies as they continue to modernize the program. Projects will support WIC Infrastructure, including technological, digital, partnership, and/or outreach infrastructure at the State agency level through activities related to outreach, innovation, program modernization, and increased equity in program access through four Tracks/objectives. This RFA includes four application Tracks, each with one Objective. The four Tracks include:1) Updating the State agencys management information system (MIS) and/or electronic benefit transfer (EBT) system to meet new Federal requirements.*Please see notes in the Tracks and Objectives section below for information about State agency model (SAM) user groups. 2) Enhancing the State agencys MIS, EBT system, and/or other technology used to provide WIC benefits and services. These enhancements must provide a better user experience for WIC applicants, participants, and staff and/or to improve longevity, flexibility, program integrity, and/or cost efficiency.3) Increasing WIC awareness among the public through adoption of new WIC branding and/or the conduct of partnership and/or outreach activities.4) Upgrading State and/or local agency technology equipment and/or supplies to improve WIC performance, security, and/or user experience (including by optimizing virtual services). Each Application Submitted Must be for Only One Track. State agencies may apply for one or more of the Tracks outlined above but are limited to one Track per application. Section 4 of the RFA provides details for the application requirements for each Track. For each Track, State agencies may apply either as an individual applicant or as the lead of a multi-State agency collaboration. Any lead of a multi-State agency collaboration will be considered the applicant and the funded recipient (i.e., the grantee). The lead State agency is responsible for completing and submitting all application components and will be the sole recipient of funding for the project; therefore responsible for all funded activities and required reporting.

The "Single Source for Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC)" grant aims to fund a Coordination and Data Management Center to continue and complete ongoing research on chronic pancreatitis, diabetes, and pancreatic cancer, focusing on understanding the pathophysiology, risk factors, and potential treatments, while promoting collaboration and data sharing among consortium members.

This grant provides funding to exceptional U.S.-based graduate students transitioning from predoctoral to postdoctoral research in kidney, urologic, or hematologic sciences, encouraging diverse talent to contribute to these fields.

The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting injectables (LAIs) such as crystalline suspensions and polymer-based implants by considering their distinct characteristics. The goal of the project is to develop a bottom-up mechanistic PBPK model for these two LAI categories by accounting for the influence of critical formulation attributes of each LAI drug product type to predict its in vivo release mechanism. The model formulation parameters and relevant physiology should be informed with suitable in vitro and in vivo experiments. A suitable preclinical animal model can be used to validate the PBPK model based IVIVCs for both LAI suspensions and polymer based implants. The use of PBPK modelling provides a unique opportunity to understand how the physicochemical properties of drug molecules/polymer, implant specific properties, critical formulation attributes, and physiology, among other things, influence the in vivo release mechanisms of LAI drug products and their disposition characteristics. Moreover, once developed, a mechanistic PBPK model can help to define the 'safe space' for critical formulation attributes relevant to the reference listed drug (RLD) product, explain sources of PK variability and extrapolate predictions to human subjects by leveraging animal model data and by accounting for species-specific physiological differences.

This funding opportunity supports researchers and organizations in improving and sustaining software tools for biomedical and health-related research by adopting best practices and enhancing collaboration within the scientific community.

This funding opportunity provides financial support to nonprofit universities, colleges, and research institutions in the U.S. to advance aquaculture research and technology, aiming to improve seafood production and sustainability.

This grant provides financial support for innovative projects that integrate solar energy production with cattle grazing, aimed at U.S.-based teams of solar developers and cattle ranchers.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit grant applications from neutral, independent institutions and/or organizations to support meetings (e.g., conferences, workgroups, roundtables) that convene a broad range of multiple stakeholders, including those with relevant expertise, to explore, research, and address issues related to medical products, policy, and surveillance methods and systems. Support includes, but is not limited to the design, planning, execution, synthesis, summary, and communication of findings from these forums to a broad range of organizations and individuals.

This funding opportunity provides financial support to schools and child nutrition programs to enhance access to locally sourced foods while integrating agricultural education activities.

This funding opportunity supports small businesses in the U.S. to develop innovative health solutions that improve outcomes and reduce disparities for minority populations and underserved communities.

This initiative provides funding opportunities for private sector entities in Jordan to collaborate with USAID in addressing key development challenges, focusing on economic growth, water security, governance, education, and the empowerment of women and youth.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.